Jove
Visualize
Contact Us

Related Experiment Videos

PSA testing: an evolving relationship with prostate cancer screening.

J Constantinou1, M R Feneley

  • 1Lister Hospital, Stevenage & Institute of Urology and Nephrology, London, UK.

Prostate Cancer and Prostatic Diseases
|November 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

External iliac vein aneurysm: a case report and review of the literature.

Journal of surgical case reports·2018
Same author

Calcification of a Synthetic Renovascular Graft in a Child.

EJVES short reports·2017
Same author

A Comparison of Accuracy of Image- versus Hardware-based Tracking Technologies in 3D Fusion in Aortic Endografting.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2016
Same author

Introduction of a Team Based Approach to Radiation Dose Reduction in the Enhancement of the Overall Radiation Safety Profile of FEVAR.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2016
Same author

Mid-term Outcomes of Renal Branches Versus Renal Fenestrations for Thoraco-abdominal Aneurysm Repair.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2016
Same author

Editor's Choice - Effect of Branch Stent Choice on Branch-related Outcomes in Complex Aortic Repair.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2016
Same journal

Focal therapy for localized prostate cancer: not all that glitters is gold.

Prostate cancer and prostatic diseases·2026
Same journal

A nationwide histopathology study reflecting the impact of the introduction of MRI in the diagnostic trajectory of prostate cancer in routine clinical care.

Prostate cancer and prostatic diseases·2026
Same journal

En-bloc vs lobe-by-lobe laser prostatectomy: where do we stand?

Prostate cancer and prostatic diseases·2026
Same journal

Response to de Riese et al. regarding "methodological and clinical considerations of MRI-based prostate cancer risk calculators".

Prostate cancer and prostatic diseases·2026
Same journal

Methodological and clinical considerations of MRI-based prostate cancer risk calculators.

Prostate cancer and prostatic diseases·2026
Same journal

Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial.

Prostate cancer and prostatic diseases·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Prostate-Specific Antigen (PSA) testing aids prostate cancer screening but faces debate. Future diagnostics will likely shift from PSA to molecular biomarkers for better early detection and prognosis.

Area of Science:

  • Urology
  • Oncology
  • Biomarker Research

Background:

  • Prostate-Specific Antigen (PSA) testing has revolutionized prostate cancer screening, leading to earlier stage diagnoses.
  • Concerns exist regarding over-diagnosis and the declining efficacy of PSA in differentiating early-stage tumors from benign conditions.
  • Traditional prognostic factors (clinical stage, PSA, Gleason grade) are becoming less distinct for localized prostate cancer.

Purpose of the Study:

  • To evaluate the evolving role of PSA testing in prostate cancer screening and diagnosis.
  • To highlight the need for advanced detection and prognostic methods beyond traditional markers.
  • To explore the potential of molecular technologies in improving prostate cancer assessment.

Main Methods:

  • Review of current literature and clinical observations regarding PSA testing efficacy.

Related Experiment Videos

  • Analysis of trends in prostate cancer presentation and diagnosis.
  • Discussion of emerging molecular technologies for cancer detection and prognosis.

    • Main Results:

    • PSA testing has shifted prostate cancer presentation towards earlier pathological stages.
    • PSA elevation is increasingly failing to distinguish tumors from benign prostatic enlargement.
    • New methods are required as traditional diagnostic distinctions are diminishing.

    Conclusions:

    • While PSA screening remains feasible, its limitations necessitate the exploration of novel diagnostic tools.
    • Molecular biomarker signatures are poised to surpass total PSA in guiding early diagnosis and prognosis.
    • Future research and clinical debate will likely center on technological advancements and molecular profiling of prostate tumors.